StonvexLoading…
StonvexStonvexStonvexCore line items from AN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $27.63B | $26.77B | $26.95B | $26.98B |
Operating Income | $1.24B | $1.31B | $1.65B | $2.02B |
Net Income | $649.10M | $692.20M | $1.02B | $1.38B |
EPS (Diluted) | $17.04 | $16.92 | $22.74 | $24.29 |
Total Assets | $14.39B | $13.00B | $11.98B | $10.06B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $58.60M | $59.80M | $60.80M | $72.60M |
Free Cash Flow OCF − CapEx | $-197.50M | $-13.80M | $313.70M | $1.34B |
Shares Outstanding | 35.20M | 39.00M | 41.60M | 47.60M |